Debiopharm Innovation Fund
Profile, fund size and portfolio
Debiopharm Innovation Fund is the corporate venture arm of Debiopharm, a pharmaceutical and biotech company. It was founded in 2006 and is based in Lausanne, Switzerland. It invests from seed to Series A. Sectors it names: healthcare and digital health, artificial intelligence, biotech and life sciences.
- Fund sizeS1
- USD 150M
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Seed to Series A |
| Sectors | Healthcare and digital health, Artificial intelligence, Biotech and life sciences |
| Geography | Global |
| Offices | Lausanne, Switzerland |
Sources: S5 Venturelab: Debiopharm Innovation Fund launches seed funding initiative; S4 Debiopharm Innovation Fund: approach.
Data behind this graphic
| Item | Companies | Share |
|---|---|---|
| Active | 17 | 94.4% |
| Exited | 1 | 5.6% |
Status as the firm tags it
Sources: S6 Debiopharm Innovation Fund: portfolio.
Data behind this graphic
| Measure | Value | Unit | Kind | Source |
|---|---|---|---|---|
| Headline size | USD 150M | Fund size | Stated by the firm or its parent | S1 |
| Companies on the firm's portfolio page | 18 | companies | Counted from the firm's own list | S6 |
Sources: S1 Debiopharm Innovation Fund: home; S6 Debiopharm Innovation Fund: portfolio.
Where it invests and who leads it
LeadersS2
- Marc CikesManaging DirectorFind on LinkedInFirm page
- Tom GibbsSenior Investment DirectorFind on LinkedInFirm page
- Vincent LepreuxInvestment DirectorFind on LinkedInFirm page
- Nicolas StalderSenior Investment AssociateFind on LinkedInFirm page
- Cedric OdjeSenior Investment AssociateFind on LinkedInFirm page
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | Debiopharm | Single source | S1 |
| Parent industry | Pharmaceuticals and biotech | Single source | S1 |
| Founded | 2006 | Single source | S5 |
| Headquarters | Lausanne, Switzerland | Single source | S3 |
| Status | Active | Single source | S1 |
| Capital source | Parent company only | Single source | S1 |
| Headline size | USD 150M (Fund size) | Single source | S1 |
| Stages | Seed, Series A | Single source | S5 |
For founders
| Item | What the firm says | Source |
|---|---|---|
| Stages | Seed, Series A | S5 |
| Contact form | www.debiopharm.com/innovation-fund/contact/ | S3 |
Portfolio
The firm's portfolio page lists 18 companies: 17 active, 1 exited.S6
| Tag | Companies | Share |
|---|---|---|
| Active | 17 | 94.4% |
| Exited | 1 | 5.6% |
Every company on the Debiopharm Innovation Fund list
18 companies, as listed on the firm's own website: 17 active, 1 exited.S6 Read the firm's list.
Active 17
- Altis Labs
- BC Platforms
- Carevive
- Fosanis
- Genialis
- Iktos
- Mekonos
- Neuroute
- Nova In Silico
- Nucleai
- Oncomfort
- Tune Insight
- VeriSIM Life
- VivoSense
- Voluntis
- Whitelab Genomics
- Yonalink
Exited 1
- Kaiku Health
History
Official pages
Read the firm's own pages for current information.
Sources
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by Debiopharm Innovation Fund or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.